Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by ZIVO Bioscience, Inc.
Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens
July 08, 2024
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study
February 07, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Announces Uplisting to OTCQB Market
January 29, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
January 23, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
OTC
ZIVO
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
October 30, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Announces Reverse Stock Split
October 26, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
October 03, 2023
From
Zivo Bioscience, Inc.
Via
GlobeNewswire
Tickers
ZIVO
ZIVOW
Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
September 19, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months
August 16, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food
July 26, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
June 30, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient
May 30, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Receives $1 Million Bridge Financing
April 05, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Announces Results of Study with its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
February 10, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech Business
October 24, 2022
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience CEO Issues Letter to Shareholders
September 23, 2022
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment
August 10, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
Zivo Bioscience Joins Russell Microcap® Index
June 27, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq
April 25, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Names Chairman John B. Payne as President and CEO
January 10, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.